The Orchestra
LurexBio's technology stack ``the orchestra``, represents a unified approach to immune engineering. Each platform—NeoTag™, Atraxis™, Atraxis-X™, and DeltaGate Logic™—addresses a distinct layer of immune activation, from tumor tagging and membrane fusion to adaptive signal control. Together, these platforms form a modular architecture that transforms immune-silent tumors into visible, targetable cells while maintaining precision, safety, and scalability across multiple disease categories.
How Our Platforms Work
A unified system of next-generation technologies that redefines how the immune system sees and responds to disease — with broad potential across oncology, autoimmune, and other immune-driven conditions. The adaptive delivery architecture also offers opportunities for collaboration and licensing, enabling precision delivery of therapeutic agents across the biotech and pharmaceutical landscape.
-
01.
Synthetic Immune Signals
NeoTag™ is designed to apply engineered immune markers that enable immune-silent tumor cells to become visible to the body's defenses.
-
02.
Precision Delivery
The Atraxis™, Atraxis-X™, and DeltaGate Logic™ platforms are designed to coordinate precision-timed therapeutic engagement, enabling controlled activation within cold tumor environments while safeguarding healthy tissue.
-
03.
Immune Activation
DeltaGate Logic™ is designed to orchestrate precision immune engagement, restoring targeted immune awareness against tumors that evade detection.
Non-Genetic Immune Tagging
Layer 1
Fusogenic Vesicle Delivery
Layer 2
Trigger-Assisted, Non-Viral Orchestration
